Lynda Carter Altman establishes fund for City of Hope and TGen to support research in sAML diagnostics and treatment

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Lynda Carter Altman and Robert Altman

The Translational Genomics Research Institute, part of City of Hope, formed a partnership with actress, singer-songwriter, and advocate, Lynda Carter Altman, to accelerate diagnostics and treatments, including precision medicine approaches, for secondary acute myeloid leukemia.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

City of Hope and Charles R. Drew University of Medicine and Science, the only Historically Black Graduate Institution west of the Mississippi River and one of only four Historically Black Medical Schools, announced the launch of a new partnership to educate a more diverse workforce in specialized medicine through internships, curriculum, training, mentorships, joint research projects, and more.
The largest clinical trial to date seeking to reduce the risk of people who have survived childhood cancer from developing heart failure found that carvedilol, a blood vessel relaxing medication, is safe for childhood cancer survivors and may improve important markers of heart injury sustained as a result of chemotherapy exposure.

Login